The global Peptide Oligonucleotide Conjugate (POC) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Peptide Oligonucleotide Conjugate (POC) competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Peptide Oligonucleotide Conjugate (POC) refer to complexes formed by connecting peptides and oligonucleotides through chemical or biological methods. This type of conjugate combines the characteristics of peptides and oligonucleotides and has a variety of potential biological functions and applications. POC can achieve targeted recognition and binding through the peptide part, and achieve functions such as gene regulation or nucleic acid interference through the oligonucleotide part. It usually has good biocompatibility and is suitable for use in the biomedical field.

The North American market for Peptide Oligonucleotide Conjugate (POC) is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Peptide Oligonucleotide Conjugate (POC) is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

Major global manufacturers of Peptide Oligonucleotide Conjugate (POC) include Creative Biogene, CPC, BOCSCI Inc., WuXi TIDES, LifeTein, Bio-Synthesis, Ajinomoto, SBS Genetech, Medtide Inc, Kaneka Corporation(Eurogentec), etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Peptide Oligonucleotide Conjugate (POC) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Peptide Oligonucleotide Conjugate (POC). The Peptide Oligonucleotide Conjugate (POC) market size, estimates, and forecasts are provided in terms of shipments (kg) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Peptide Oligonucleotide Conjugate (POC) market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Peptide Oligonucleotide Conjugate (POC) manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Peptide Oligonucleotide Conjugate (POC) Market Report

Report Metric	Details
Report Name	Peptide Oligonucleotide Conjugate (POC) Market
Segment by Type	Single Chain Double Chain
by Application	Diagnostic Reagents Drug Development Gene Therapy Other
Production by Region	North America Europe China Japan
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Creative Biogene, CPC, BOCSCI Inc., WuXi TIDES, LifeTein, Bio-Synthesis, Ajinomoto, SBS Genetech, Medtide Inc, Kaneka Corporation(Eurogentec)
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Peptide Oligonucleotide Conjugate (POC) manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
Chapter 3: Examines Peptide Oligonucleotide Conjugate (POC) production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
Chapter 4: Analyzes Peptide Oligonucleotide Conjugate (POC) consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 10: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Peptide Oligonucleotide Conjugate (POC) Market report?

Ans: The main players in the Peptide Oligonucleotide Conjugate (POC) Market are Creative Biogene, CPC, BOCSCI Inc., WuXi TIDES, LifeTein, Bio-Synthesis, Ajinomoto, SBS Genetech, Medtide Inc, Kaneka Corporation(Eurogentec)

What are the Application segmentation covered in the Peptide Oligonucleotide Conjugate (POC) Market report?

Ans: The Applications covered in the Peptide Oligonucleotide Conjugate (POC) Market report are Diagnostic Reagents, Drug Development, Gene Therapy, Other

What are the Type segmentation covered in the Peptide Oligonucleotide Conjugate (POC) Market report?

Ans: The Types covered in the Peptide Oligonucleotide Conjugate (POC) Market report are Single Chain, Double Chain

1 Peptide Oligonucleotide Conjugate (POC) Market Overview

1.1 Product Definition

1.2 Peptide Oligonucleotide Conjugate (POC) by Type

1.2.1 Global Peptide Oligonucleotide Conjugate (POC) Market Value Growth Rate Analysis by Type: 2025 vs 2032

1.2.2 Single Chain

1.2.3 Double Chain

1.3 Peptide Oligonucleotide Conjugate (POC) by Application

1.3.1 Global Peptide Oligonucleotide Conjugate (POC) Market Value Growth Rate Analysis by Application: 2025 vs 2032

1.3.2 Diagnostic Reagents

1.3.3 Drug Development

1.3.4 Gene Therapy

1.3.5 Other

1.4 Global Market Growth Prospects

1.4.1 Global Peptide Oligonucleotide Conjugate (POC) Production Value Estimates and Forecasts (2021–2032)

1.4.2 Global Peptide Oligonucleotide Conjugate (POC) Production Capacity Estimates and Forecasts (2021–2032)

1.4.3 Global Peptide Oligonucleotide Conjugate (POC) Production Estimates and Forecasts (2021–2032)

1.4.4 Global Peptide Oligonucleotide Conjugate (POC) Market Average Price Estimates and Forecasts (2021–2032)

1.5 Assumptions and Limitations

2 Market Competition by Manufacturers

2.1 Global Peptide Oligonucleotide Conjugate (POC) Production Market Share by Manufacturers (2021–2026)

2.2 Global Peptide Oligonucleotide Conjugate (POC) Production Value Market Share by Manufacturers (2021–2026)

2.3 Global Key Players of Peptide Oligonucleotide Conjugate (POC), Industry Ranking, 2024 vs 2025

2.4 Global Peptide Oligonucleotide Conjugate (POC) Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.5 Global Peptide Oligonucleotide Conjugate (POC) Average Price by Manufacturers (2021–2026)

2.6 Global Key Manufacturers of Peptide Oligonucleotide Conjugate (POC), Manufacturing Footprints and Headquarters

2.7 Global Key Manufacturers of Peptide Oligonucleotide Conjugate (POC), Product Offerings and Applications

2.8 Global Key Manufacturers of Peptide Oligonucleotide Conjugate (POC), Date of Entry into the Industry

2.9 Peptide Oligonucleotide Conjugate (POC) Market Competitive Situation and Trends

2.9.1 Peptide Oligonucleotide Conjugate (POC) Market Concentration Rate

2.9.2 Top 5 and Top 10 Global Peptide Oligonucleotide Conjugate (POC) Players Market Share by Revenue

2.10 Mergers & Acquisitions and Expansion

3 Peptide Oligonucleotide Conjugate (POC) Production by Region

3.1 Global Peptide Oligonucleotide Conjugate (POC) Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032

3.2 Global Peptide Oligonucleotide Conjugate (POC) Production Value by Region (2021–2032)

3.2.1 Global Peptide Oligonucleotide Conjugate (POC) Production Value by Region (2021–2026)

3.2.2 Global Forecasted Production Value of Peptide Oligonucleotide Conjugate (POC) by Region (2027–2032)

3.3 Global Peptide Oligonucleotide Conjugate (POC) Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032

3.4 Global Peptide Oligonucleotide Conjugate (POC) Production Volume by Region (2021–2032)

3.4.1 Global Peptide Oligonucleotide Conjugate (POC) Production by Region (2021–2026)

3.4.2 Global Forecasted Production of Peptide Oligonucleotide Conjugate (POC) by Region (2027–2032)

3.5 Global Peptide Oligonucleotide Conjugate (POC) Market Price Analysis by Region (2021–2026)

3.6 Global Peptide Oligonucleotide Conjugate (POC) Production, Value, and Year-over-Year Growth

3.6.1 North America Peptide Oligonucleotide Conjugate (POC) Production Value Estimates and Forecasts (2021–2032)

3.6.2 Europe Peptide Oligonucleotide Conjugate (POC) Production Value Estimates and Forecasts (2021–2032)

3.6.3 China Peptide Oligonucleotide Conjugate (POC) Production Value Estimates and Forecasts (2021–2032)

3.6.4 Japan Peptide Oligonucleotide Conjugate (POC) Production Value Estimates and Forecasts (2021–2032)

4 Peptide Oligonucleotide Conjugate (POC) Consumption by Region

4.1 Global Peptide Oligonucleotide Conjugate (POC) Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032

4.2 Global Peptide Oligonucleotide Conjugate (POC) Consumption by Region (2021–2032)

4.2.1 Global Peptide Oligonucleotide Conjugate (POC) Consumption by Region (2021–2026)

4.2.2 Global Peptide Oligonucleotide Conjugate (POC) Forecasted Consumption by Region (2027–2032)

4.3 North America

4.3.1 North America Peptide Oligonucleotide Conjugate (POC) Consumption Growth Rate by Country: 2021 vs 2025 vs 2032

4.3.2 North America Peptide Oligonucleotide Conjugate (POC) Consumption by Country (2021–2032)

4.3.3 U.S.

4.3.4 Canada

4.4 Europe

4.4.1 Europe Peptide Oligonucleotide Conjugate (POC) Consumption Growth Rate by Country: 2021 vs 2025 vs 2032

4.4.2 Europe Peptide Oligonucleotide Conjugate (POC) Consumption by Country (2021–2032)

4.4.3 Germany

4.4.4 France

4.4.5 U.K.

4.4.6 Italy

4.4.7 Russia

4.5 Asia Pacific

4.5.1 Asia Pacific Peptide Oligonucleotide Conjugate (POC) Consumption Growth Rate by Region: 2021 vs 2025 vs 2032

4.5.2 Asia Pacific Peptide Oligonucleotide Conjugate (POC) Consumption by Region (2021–2032)

4.5.3 China

4.5.4 Japan

4.5.5 South Korea

4.5.6 China Taiwan

4.5.7 Southeast Asia

4.5.8 India

4.6 Latin America, Middle East & Africa

4.6.1 Latin America, Middle East & Africa Peptide Oligonucleotide Conjugate (POC) Consumption Growth Rate by Country: 2021 vs 2025 vs 2032

4.6.2 Latin America, Middle East & Africa Peptide Oligonucleotide Conjugate (POC) Consumption by Country (2021–2032)

4.6.3 Mexico

4.6.4 Brazil

4.6.5 Turkey

4.6.6 GCC Countries

5 Segment by Type

5.1 Global Peptide Oligonucleotide Conjugate (POC) Production by Type (2021–2032)

5.1.1 Global Peptide Oligonucleotide Conjugate (POC) Production by Type (2021–2026)

5.1.2 Global Peptide Oligonucleotide Conjugate (POC) Production by Type (2027–2032)

5.1.3 Global Peptide Oligonucleotide Conjugate (POC) Production Market Share by Type (2021–2032)

5.2 Global Peptide Oligonucleotide Conjugate (POC) Production Value by Type (2021–2032)

5.2.1 Global Peptide Oligonucleotide Conjugate (POC) Production Value by Type (2021–2026)

5.2.2 Global Peptide Oligonucleotide Conjugate (POC) Production Value by Type (2027–2032)

5.2.3 Global Peptide Oligonucleotide Conjugate (POC) Production Value Market Share by Type (2021–2032)

5.3 Global Peptide Oligonucleotide Conjugate (POC) Price by Type (2021–2032)

6 Segment by Application

6.1 Global Peptide Oligonucleotide Conjugate (POC) Production by Application (2021–2032)

6.1.1 Global Peptide Oligonucleotide Conjugate (POC) Production by Application (2021–2026)

6.1.2 Global Peptide Oligonucleotide Conjugate (POC) Production by Application (2027–2032)

6.1.3 Global Peptide Oligonucleotide Conjugate (POC) Production Market Share by Application (2021–2032)

6.2 Global Peptide Oligonucleotide Conjugate (POC) Production Value by Application (2021–2032)

6.2.1 Global Peptide Oligonucleotide Conjugate (POC) Production Value by Application (2021–2026)

6.2.2 Global Peptide Oligonucleotide Conjugate (POC) Production Value by Application (2027–2032)

6.2.3 Global Peptide Oligonucleotide Conjugate (POC) Production Value Market Share by Application (2021–2032)

6.3 Global Peptide Oligonucleotide Conjugate (POC) Price by Application (2021–2032)

7 Key Companies Profiled

7.1 Creative Biogene

7.1.1 Creative Biogene Peptide Oligonucleotide Conjugate (POC) Company Information

7.1.2 Creative Biogene Peptide Oligonucleotide Conjugate (POC) Product Portfolio

7.1.3 Creative Biogene Peptide Oligonucleotide Conjugate (POC) Production, Value, Price, and Gross Margin (2021–2026)

7.1.4 Creative Biogene Main Business and Markets Served

7.1.5 Creative Biogene Recent Developments/Updates

7.2 CPC

7.2.1 CPC Peptide Oligonucleotide Conjugate (POC) Company Information

7.2.2 CPC Peptide Oligonucleotide Conjugate (POC) Product Portfolio

7.2.3 CPC Peptide Oligonucleotide Conjugate (POC) Production, Value, Price, and Gross Margin (2021–2026)

7.2.4 CPC Main Business and Markets Served

7.2.5 CPC Recent Developments/Updates

7.3 BOCSCI Inc.

7.3.1 BOCSCI Inc. Peptide Oligonucleotide Conjugate (POC) Company Information

7.3.2 BOCSCI Inc. Peptide Oligonucleotide Conjugate (POC) Product Portfolio

7.3.3 BOCSCI Inc. Peptide Oligonucleotide Conjugate (POC) Production, Value, Price, and Gross Margin (2021–2026)

7.3.4 BOCSCI Inc. Main Business and Markets Served

7.3.5 BOCSCI Inc. Recent Developments/Updates

7.4 WuXi TIDES

7.4.1 WuXi TIDES Peptide Oligonucleotide Conjugate (POC) Company Information

7.4.2 WuXi TIDES Peptide Oligonucleotide Conjugate (POC) Product Portfolio

7.4.3 WuXi TIDES Peptide Oligonucleotide Conjugate (POC) Production, Value, Price, and Gross Margin (2021–2026)

7.4.4 WuXi TIDES Main Business and Markets Served

7.4.5 WuXi TIDES Recent Developments/Updates

7.5 LifeTein

7.5.1 LifeTein Peptide Oligonucleotide Conjugate (POC) Company Information

7.5.2 LifeTein Peptide Oligonucleotide Conjugate (POC) Product Portfolio

7.5.3 LifeTein Peptide Oligonucleotide Conjugate (POC) Production, Value, Price, and Gross Margin (2021–2026)

7.5.4 LifeTein Main Business and Markets Served

7.5.5 LifeTein Recent Developments/Updates

7.6 Bio-Synthesis

7.6.1 Bio-Synthesis Peptide Oligonucleotide Conjugate (POC) Company Information

7.6.2 Bio-Synthesis Peptide Oligonucleotide Conjugate (POC) Product Portfolio

7.6.3 Bio-Synthesis Peptide Oligonucleotide Conjugate (POC) Production, Value, Price, and Gross Margin (2021–2026)

7.6.4 Bio-Synthesis Main Business and Markets Served

7.6.5 Bio-Synthesis Recent Developments/Updates

7.7 Ajinomoto

7.7.1 Ajinomoto Peptide Oligonucleotide Conjugate (POC) Company Information

7.7.2 Ajinomoto Peptide Oligonucleotide Conjugate (POC) Product Portfolio

7.7.3 Ajinomoto Peptide Oligonucleotide Conjugate (POC) Production, Value, Price, and Gross Margin (2021–2026)

7.7.4 Ajinomoto Main Business and Markets Served

7.7.5 Ajinomoto Recent Developments/Updates

7.8 SBS Genetech

7.8.1 SBS Genetech Peptide Oligonucleotide Conjugate (POC) Company Information

7.8.2 SBS Genetech Peptide Oligonucleotide Conjugate (POC) Product Portfolio

7.8.3 SBS Genetech Peptide Oligonucleotide Conjugate (POC) Production, Value, Price, and Gross Margin (2021–2026)

7.8.4 SBS Genetech Main Business and Markets Served

7.8.5 SBS Genetech Recent Developments/Updates

7.9 Medtide Inc

7.9.1 Medtide Inc Peptide Oligonucleotide Conjugate (POC) Company Information

7.9.2 Medtide Inc Peptide Oligonucleotide Conjugate (POC) Product Portfolio

7.9.3 Medtide Inc Peptide Oligonucleotide Conjugate (POC) Production, Value, Price, and Gross Margin (2021–2026)

7.9.4 Medtide Inc Main Business and Markets Served

7.9.5 Medtide Inc Recent Developments/Updates

7.10 Kaneka Corporation(Eurogentec)

7.10.1 Kaneka Corporation(Eurogentec) Peptide Oligonucleotide Conjugate (POC) Company Information

7.10.2 Kaneka Corporation(Eurogentec) Peptide Oligonucleotide Conjugate (POC) Product Portfolio

7.10.3 Kaneka Corporation(Eurogentec) Peptide Oligonucleotide Conjugate (POC) Production, Value, Price, and Gross Margin (2021–2026)

7.10.4 Kaneka Corporation(Eurogentec) Main Business and Markets Served

7.10.5 Kaneka Corporation(Eurogentec) Recent Developments/Updates

8 Industry Chain and Sales Channels Analysis

8.1 Peptide Oligonucleotide Conjugate (POC) Industry Chain Analysis

8.2 Peptide Oligonucleotide Conjugate (POC) Raw Material Supply Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.3 Peptide Oligonucleotide Conjugate (POC) Production Modes and Processes

8.4 Peptide Oligonucleotide Conjugate (POC) Sales and Marketing

8.4.1 Peptide Oligonucleotide Conjugate (POC) Sales Channels

8.4.2 Peptide Oligonucleotide Conjugate (POC) Distributors

8.5 Peptide Oligonucleotide Conjugate (POC) Customer Analysis

9 Peptide Oligonucleotide Conjugate (POC) Market Dynamics

9.1 Peptide Oligonucleotide Conjugate (POC) Industry Trends

9.2 Peptide Oligonucleotide Conjugate (POC) Market Drivers

9.3 Peptide Oligonucleotide Conjugate (POC) Market Challenges

9.4 Peptide Oligonucleotide Conjugate (POC) Market Restraints

9.5 Impact of U.S. Tariffs

10 Research Findings and Conclusion

11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Author List

11.4 Disclaimer

FEATURED COMPANIES

Kaneka Corporation (Eurogentec)

List of Tables

Table 1. Global Peptide Oligonucleotide Conjugate (POC) Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Peptide Oligonucleotide Conjugate (POC) Market Value by Application (US$ Million), 2025 vs 2032

Table 3. Global Peptide Oligonucleotide Conjugate (POC) Production Capacity (kg) by Manufacturers in 2025

Table 4. Global Peptide Oligonucleotide Conjugate (POC) Production by Manufacturers (kg), 2021–2026

Table 5. Global Peptide Oligonucleotide Conjugate (POC) Production Market Share by Manufacturers (2021–2026)

Table 6. Global Peptide Oligonucleotide Conjugate (POC) Production Value by Manufacturers (US$ Million), 2021–2026

Table 7. Global Peptide Oligonucleotide Conjugate (POC) Production Value Share by Manufacturers (2021–2026)

Table 8. Global Key Players of Peptide Oligonucleotide Conjugate (POC), Industry Ranking, 2024 vs 2025

Table 9. Classification of Companies by Tier (Tier 1, Tier 2, Tier 3), based on Peptide Oligonucleotide Conjugate (POC) Production Value, 2025

Table 10. Global Market Peptide Oligonucleotide Conjugate (POC) Average Price by Manufacturers (US$/g), 2021–2026

Table 11. Global Key Manufacturers of Peptide Oligonucleotide Conjugate (POC), Manufacturing Footprints and Headquarters

Table 12. Global Key Manufacturers of Peptide Oligonucleotide Conjugate (POC), Product Offerings and Applications

Table 13. Global Key Manufacturers of Peptide Oligonucleotide Conjugate (POC), Date of Entry into the Industry

Table 14. Global Peptide Oligonucleotide Conjugate (POC) Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 15. Mergers & Acquisitions and Expansion Plans

Table 16. Global Peptide Oligonucleotide Conjugate (POC) Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 17. Global Peptide Oligonucleotide Conjugate (POC) Production Value (US$ Million) by Region (2021–2026)

Table 18. Global Peptide Oligonucleotide Conjugate (POC) Production Value Market Share by Region (2021–2026)

Table 19. Global Peptide Oligonucleotide Conjugate (POC) Production Value (US$ Million) Forecast by Region (2027–2032)

Table 20. Global Peptide Oligonucleotide Conjugate (POC) Production Value Market Share Forecast by Region (2027–2032)

Table 21. Global Peptide Oligonucleotide Conjugate (POC) Production Comparison by Region: 2021 vs 2025 vs 2032 (kg)

Table 22. Global Peptide Oligonucleotide Conjugate (POC) Production (kg) by Region (2021–2026)

Table 23. Global Peptide Oligonucleotide Conjugate (POC) Production Market Share by Region (2021–2026)

Table 24. Global Peptide Oligonucleotide Conjugate (POC) Production (kg) Forecast by Region (2027–2032)

Table 25. Global Peptide Oligonucleotide Conjugate (POC) Production Market Share Forecast by Region (2027–2032)

Table 26. Global Peptide Oligonucleotide Conjugate (POC) Market Average Price (US$/g) by Region (2021–2026)

Table 27. Global Peptide Oligonucleotide Conjugate (POC) Market Average Price (US$/g) by Region (2027–2032)

Table 28. Global Peptide Oligonucleotide Conjugate (POC) Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (kg)

Table 29. Global Peptide Oligonucleotide Conjugate (POC) Consumption by Region (kg), 2021–2026

Table 30. Global Peptide Oligonucleotide Conjugate (POC) Consumption Market Share by Region (2021–2026)

Table 31. Global Peptide Oligonucleotide Conjugate (POC) Forecasted Consumption by Region (kg), 2027–2032

Table 32. Global Peptide Oligonucleotide Conjugate (POC) Forecasted Consumption Market Share by Region (2027–2032)

Table 33. North America Peptide Oligonucleotide Conjugate (POC) Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (kg)

Table 34. North America Peptide Oligonucleotide Conjugate (POC) Consumption by Country (kg), 2021–2026

Table 35. North America Peptide Oligonucleotide Conjugate (POC) Consumption by Country (kg), 2027–2032

Table 36. Europe Peptide Oligonucleotide Conjugate (POC) Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (kg)

Table 37. Europe Peptide Oligonucleotide Conjugate (POC) Consumption by Country (kg), 2021–2026

Table 38. Europe Peptide Oligonucleotide Conjugate (POC) Consumption by Country (kg), 2027–2032

Table 39. Asia Pacific Peptide Oligonucleotide Conjugate (POC) Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (kg)

Table 40. Asia Pacific Peptide Oligonucleotide Conjugate (POC) Consumption by Region (kg), 2021–2026

Table 41. Asia Pacific Peptide Oligonucleotide Conjugate (POC) Consumption by Region (kg), 2027–2032

Table 42. Latin America, Middle East & Africa Peptide Oligonucleotide Conjugate (POC) Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (kg)

Table 43. Latin America, Middle East & Africa Peptide Oligonucleotide Conjugate (POC) Consumption by Country (kg), 2021–2026

Table 44. Latin America, Middle East & Africa Peptide Oligonucleotide Conjugate (POC) Consumption by Country (kg), 2027–2032

Table 45. Global Peptide Oligonucleotide Conjugate (POC) Production (kg) by Type (2021–2026)

Table 46. Global Peptide Oligonucleotide Conjugate (POC) Production (kg) by Type (2027–2032)

Table 47. Global Peptide Oligonucleotide Conjugate (POC) Production Market Share by Type (2021–2026)

Table 48. Global Peptide Oligonucleotide Conjugate (POC) Production Market Share by Type (2027–2032)

Table 49. Global Peptide Oligonucleotide Conjugate (POC) Production Value (US$ Million) by Type (2021–2026)

Table 50. Global Peptide Oligonucleotide Conjugate (POC) Production Value (US$ Million) by Type (2027–2032)

Table 51. Global Peptide Oligonucleotide Conjugate (POC) Production Value Market Share by Type (2021–2026)

Table 52. Global Peptide Oligonucleotide Conjugate (POC) Production Value Market Share by Type (2027–2032)

Table 53. Global Peptide Oligonucleotide Conjugate (POC) Price (US$/g) by Type (2021–2026)

Table 54. Global Peptide Oligonucleotide Conjugate (POC) Price (US$/g) by Type (2027–2032)

Table 55. Global Peptide Oligonucleotide Conjugate (POC) Production (kg) by Application (2021–2026)

Table 56. Global Peptide Oligonucleotide Conjugate (POC) Production (kg) by Application (2027–2032)

Table 57. Global Peptide Oligonucleotide Conjugate (POC) Production Market Share by Application (2021–2026)

Table 58. Global Peptide Oligonucleotide Conjugate (POC) Production Market Share by Application (2027–2032)

Table 59. Global Peptide Oligonucleotide Conjugate (POC) Production Value (US$ Million) by Application (2021–2026)

Table 60. Global Peptide Oligonucleotide Conjugate (POC) Production Value (US$ Million) by Application (2027–2032)

Table 61. Global Peptide Oligonucleotide Conjugate (POC) Production Value Market Share by Application (2021–2026)

Table 62. Global Peptide Oligonucleotide Conjugate (POC) Production Value Market Share by Application (2027–2032)

Table 63. Global Peptide Oligonucleotide Conjugate (POC) Price (US$/g) by Application (2021–2026)

Table 64. Global Peptide Oligonucleotide Conjugate (POC) Price (US$/g) by Application (2027–2032)

Table 65. Creative Biogene Peptide Oligonucleotide Conjugate (POC) Company Information

Table 66. Creative Biogene Peptide Oligonucleotide Conjugate (POC) Specification and Application

Table 67. Creative Biogene Peptide Oligonucleotide Conjugate (POC) Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)

Table 68. Creative Biogene Main Business and Markets Served

Table 69. Creative Biogene Recent Developments/Updates

Table 70. CPC Peptide Oligonucleotide Conjugate (POC) Company Information

Table 71. CPC Peptide Oligonucleotide Conjugate (POC) Specification and Application

Table 72. CPC Peptide Oligonucleotide Conjugate (POC) Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)

Table 73. CPC Main Business and Markets Served

Table 74. CPC Recent Developments/Updates

Table 75. BOCSCI Inc. Peptide Oligonucleotide Conjugate (POC) Company Information

Table 76. BOCSCI Inc. Peptide Oligonucleotide Conjugate (POC) Specification and Application

Table 77. BOCSCI Inc. Peptide Oligonucleotide Conjugate (POC) Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)

Table 78. BOCSCI Inc. Main Business and Markets Served

Table 79. BOCSCI Inc. Recent Developments/Updates

Table 80. WuXi TIDES Peptide Oligonucleotide Conjugate (POC) Company Information

Table 81. WuXi TIDES Peptide Oligonucleotide Conjugate (POC) Specification and Application

Table 82. WuXi TIDES Peptide Oligonucleotide Conjugate (POC) Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)

Table 83. WuXi TIDES Main Business and Markets Served

Table 84. WuXi TIDES Recent Developments/Updates

Table 85. LifeTein Peptide Oligonucleotide Conjugate (POC) Company Information

Table 86. LifeTein Peptide Oligonucleotide Conjugate (POC) Specification and Application

Table 87. LifeTein Peptide Oligonucleotide Conjugate (POC) Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)

Table 88. LifeTein Main Business and Markets Served

Table 89. LifeTein Recent Developments/Updates

Table 90. Bio-Synthesis Peptide Oligonucleotide Conjugate (POC) Company Information

Table 91. Bio-Synthesis Peptide Oligonucleotide Conjugate (POC) Specification and Application

Table 92. Bio-Synthesis Peptide Oligonucleotide Conjugate (POC) Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)

Table 93. Bio-Synthesis Main Business and Markets Served

Table 94. Bio-Synthesis Recent Developments/Updates

Table 95. Ajinomoto Peptide Oligonucleotide Conjugate (POC) Company Information

Table 96. Ajinomoto Peptide Oligonucleotide Conjugate (POC) Specification and Application

Table 97. Ajinomoto Peptide Oligonucleotide Conjugate (POC) Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)

Table 98. Ajinomoto Main Business and Markets Served

Table 99. Ajinomoto Recent Developments/Updates

Table 100. SBS Genetech Peptide Oligonucleotide Conjugate (POC) Company Information

Table 101. SBS Genetech Peptide Oligonucleotide Conjugate (POC) Specification and Application

Table 102. SBS Genetech Peptide Oligonucleotide Conjugate (POC) Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)

Table 103. SBS Genetech Main Business and Markets Served

Table 104. SBS Genetech Recent Developments/Updates

Table 105. Medtide Inc Peptide Oligonucleotide Conjugate (POC) Company Information

Table 106. Medtide Inc Peptide Oligonucleotide Conjugate (POC) Specification and Application

Table 107. Medtide Inc Peptide Oligonucleotide Conjugate (POC) Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)

Table 108. Medtide Inc Main Business and Markets Served

Table 109. Medtide Inc Recent Developments/Updates

Table 110. Kaneka Corporation(Eurogentec) Peptide Oligonucleotide Conjugate (POC) Company Information

Table 111. Kaneka Corporation(Eurogentec) Peptide Oligonucleotide Conjugate (POC) Specification and Application

Table 112. Kaneka Corporation(Eurogentec) Peptide Oligonucleotide Conjugate (POC) Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)

Table 113. Kaneka Corporation(Eurogentec) Main Business and Markets Served

Table 114. Kaneka Corporation(Eurogentec) Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. Peptide Oligonucleotide Conjugate (POC) Distributors List

Table 118. Peptide Oligonucleotide Conjugate (POC) Customers List

Table 119. Peptide Oligonucleotide Conjugate (POC) Market Trends

Table 120. Peptide Oligonucleotide Conjugate (POC) Market Drivers

Table 121. Peptide Oligonucleotide Conjugate (POC) Market Challenges

Table 122. Peptide Oligonucleotide Conjugate (POC) Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Product Picture of Peptide Oligonucleotide Conjugate (POC)

Figure 2. Global Peptide Oligonucleotide Conjugate (POC) Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Peptide Oligonucleotide Conjugate (POC) Market Share by Type: 2025 vs 2032

Figure 4. Single Chain Product Picture

Figure 5. Double Chain Product Picture

Figure 6. Global Peptide Oligonucleotide Conjugate (POC) Market Value by Application (US$ Million), 2021–2032

Figure 7. Global Peptide Oligonucleotide Conjugate (POC) Market Share by Application: 2025 vs 2032

Figure 8. Diagnostic Reagents

Figure 9. Drug Development

Figure 10. Gene Therapy

Figure 11. Other

Figure 12. Global Peptide Oligonucleotide Conjugate (POC) Production Value (US$ Million), 2021 vs 2025 vs 2032

Figure 13. Global Peptide Oligonucleotide Conjugate (POC) Production Value (US$ Million), 2021–2032

Figure 14. Global Peptide Oligonucleotide Conjugate (POC) Production Capacity (kg), 2021–2032

Figure 15. Global Peptide Oligonucleotide Conjugate (POC) Production (kg), 2021–2032

Figure 16. Global Peptide Oligonucleotide Conjugate (POC) Average Price (US$/g), 2021–2032

Figure 17. Peptide Oligonucleotide Conjugate (POC) Report Years Considered

Figure 18. Peptide Oligonucleotide Conjugate (POC) Production Share by Manufacturers in 2025

Figure 19. Global Peptide Oligonucleotide Conjugate (POC) Production Value Share by Manufacturers (2025)

Figure 20. Peptide Oligonucleotide Conjugate (POC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 21. Top 5 and Top 10 Global Players: Market Share by Peptide Oligonucleotide Conjugate (POC) Revenue in 2025

Figure 22. Global Peptide Oligonucleotide Conjugate (POC) Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)

Figure 23. Global Peptide Oligonucleotide Conjugate (POC) Production Value Market Share by Region: 2021 vs 2025 vs 2032

Figure 24. Global Peptide Oligonucleotide Conjugate (POC) Production Comparison by Region: 2021 vs 2025 vs 2032 (kg)

Figure 25. Global Peptide Oligonucleotide Conjugate (POC) Production Market Share by Region: 2021 vs 2025 vs 2032

Figure 26. North America Peptide Oligonucleotide Conjugate (POC) Production Value (US$ Million) Growth Rate (2021–2032)

Figure 27. Europe Peptide Oligonucleotide Conjugate (POC) Production Value (US$ Million) Growth Rate (2021–2032)

Figure 28. China Peptide Oligonucleotide Conjugate (POC) Production Value (US$ Million) Growth Rate (2021–2032)

Figure 29. Japan Peptide Oligonucleotide Conjugate (POC) Production Value (US$ Million) Growth Rate (2021–2032)

Figure 30. Global Peptide Oligonucleotide Conjugate (POC) Consumption by Region: 2021 vs 2025 vs 2032 (kg)

Figure 31. Global Peptide Oligonucleotide Conjugate (POC) Consumption Market Share by Region: 2021 vs 2025 vs 2032

Figure 32. North America Peptide Oligonucleotide Conjugate (POC) Consumption and Growth Rate (kg), 2021–2032

Figure 33. North America Peptide Oligonucleotide Conjugate (POC) Consumption Market Share by Country (2021–2032)

Figure 34. U.S. Peptide Oligonucleotide Conjugate (POC) Consumption and Growth Rate (kg), 2021–2032

Figure 35. Canada Peptide Oligonucleotide Conjugate (POC) Consumption and Growth Rate (kg), 2021–2032

Figure 36. Europe Peptide Oligonucleotide Conjugate (POC) Consumption and Growth Rate (kg), 2021–2032

Figure 37. Europe Peptide Oligonucleotide Conjugate (POC) Consumption Market Share by Country (2021–2032)

Figure 38. Germany Peptide Oligonucleotide Conjugate (POC) Consumption and Growth Rate (kg), 2021–2032

Figure 39. France Peptide Oligonucleotide Conjugate (POC) Consumption and Growth Rate (kg), 2021–2032

Figure 40. U.K. Peptide Oligonucleotide Conjugate (POC) Consumption and Growth Rate (kg), 2021–2032

Figure 41. Italy Peptide Oligonucleotide Conjugate (POC) Consumption and Growth Rate (kg), 2021–2032

Figure 42. Russia Peptide Oligonucleotide Conjugate (POC) Consumption and Growth Rate (kg), 2021–2032

Figure 43. Asia Pacific Peptide Oligonucleotide Conjugate (POC) Consumption and Growth Rate (kg), 2021–2032

Figure 44. Asia Pacific Peptide Oligonucleotide Conjugate (POC) Consumption Market Share by Region (2021–2032)

Figure 45. China Peptide Oligonucleotide Conjugate (POC) Consumption and Growth Rate (kg), 2021–2032

Figure 46. Japan Peptide Oligonucleotide Conjugate (POC) Consumption and Growth Rate (kg), 2021–2032

Figure 47. South Korea Peptide Oligonucleotide Conjugate (POC) Consumption and Growth Rate (kg), 2021–2032

Figure 48. China Taiwan Peptide Oligonucleotide Conjugate (POC) Consumption and Growth Rate (kg), 2021–2032

Figure 49. Southeast Asia Peptide Oligonucleotide Conjugate (POC) Consumption and Growth Rate (kg), 2021–2032

Figure 50. India Peptide Oligonucleotide Conjugate (POC) Consumption and Growth Rate (kg), 2021–2032

Figure 51. Latin America, Middle East & Africa Peptide Oligonucleotide Conjugate (POC) Consumption and Growth Rate (kg), 2021–2032

Figure 52. Latin America, Middle East & Africa Peptide Oligonucleotide Conjugate (POC) Consumption Market Share by Country (2021–2032)

Figure 53. Mexico Peptide Oligonucleotide Conjugate (POC) Consumption and Growth Rate (kg), 2021–2032

Figure 54. Brazil Peptide Oligonucleotide Conjugate (POC) Consumption and Growth Rate (kg), 2021–2032

Figure 55. Turkey Peptide Oligonucleotide Conjugate (POC) Consumption and Growth Rate (kg), 2021–2032

Figure 56. GCC Countries Peptide Oligonucleotide Conjugate (POC) Consumption and Growth Rate (kg), 2021–2032

Figure 57. Global Production Market Share of Peptide Oligonucleotide Conjugate (POC) by Type (2021–2032)

Figure 58. Global Production Value Market Share of Peptide Oligonucleotide Conjugate (POC) by Type (2021–2032)

Figure 59. Global Peptide Oligonucleotide Conjugate (POC) Price (US$/g) by Type (2021–2032)

Figure 60. Global Production Market Share of Peptide Oligonucleotide Conjugate (POC) by Application (2021–2032)

Figure 61. Global Production Value Market Share of Peptide Oligonucleotide Conjugate (POC) by Application (2021–2032)

Figure 62. Global Peptide Oligonucleotide Conjugate (POC) Price (US$/g) by Application (2021–2032)

Figure 63. Peptide Oligonucleotide Conjugate (POC) Value Chain

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions